LBIO (Longevity Biomedical) NonCurrent Deferred Liabilities: $0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Longevity Biomedical NonCurrent Deferred Liabilities?

Longevity Biomedical LBIO NonCurrent Deferred Liabilities is $0.00 Mil as of . 20.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Longevity Biomedical's non-current deferred liabilities for the quarter that ended in . 20 was $0.00 Mil.

Longevity Biomedical NonCurrent Deferred Liabilities Related Terms

Longevity Biomedical NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical NonCurrent Deferred Liabilities Chart

Longevity Biomedical Annual Data
Trend
NonCurrent Deferred Liabilities

Longevity Biomedical Semi-Annual Data
NonCurrent Deferred Liabilities
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
Longevity Biomedical (LBIO) has a NonCurrent Deferred Liabilities of $0.00 Mil as of . 20. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's NonCurrent Deferred Liabilities too high?
Longevity Biomedical's current NonCurrent Deferred Liabilities is $0.00 Mil.
How does Longevity Biomedical's NonCurrent Deferred Liabilities compare to ?
Longevity Biomedical's NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Longevity Biomedical and its competitors. Longevity Biomedical's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current NonCurrent Deferred Liabilities of $0.00 Mil. The current NonCurrent Deferred Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current NonCurrent Deferred Liabilities is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.